BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KN060 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KN060\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07191899-546@assetmemo.bio
DTSTAMP:20261121T004553Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:KN060: Phase 1 readout est. (NCT07191899)
DESCRIPTION:KN060\, phase 1\, Hypertension.\nStudy: To Evaluate the Efficac
 y and Safety of KN060 in Essential Hypertension\nEstimated primary complet
 ion: 30 December 2026. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/kn060#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07191899
URL:https://assetmemo.bio/drug/kn060#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07201467-546@assetmemo.bio
DTSTAMP:20261121T004553Z
DTSTART;VALUE=DATE:20270815
DTEND;VALUE=DATE:20270816
SUMMARY:KN060: Phase 1/2 readout est. (NCT07201467)
DESCRIPTION:KN060\, phase 1/2\, Chronic Kidney Disease.\nStudy: To Assess t
 he Safety\, Tolerability\, Pharmacokinetics and Pharmacodynamics of KN060 
 in ESRD Dialysis Patients\nEstimated primary completion: 15 August 2027. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/kn060#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT07201467
URL:https://assetmemo.bio/drug/kn060#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
